Cytokinetics | CYTK - Current Liabilities


Cytokinetics reported $181.43M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 361.44M 55.91M Jun/2026
Amgen USD 25.5B 547M Jun/2026
Arca Biopharma USD 22.97M 6.34M Jun/2026
Bayer EUR 32.27B 1.19B Jun/2026
Biogen USD 3.92B 918.2M Jun/2026
Brainstorm Cell Therapeutics USD 12.38M 621K Jun/2026
Bristol-Myers Squibb USD 18.66B 499M Jun/2026
Capricor Therapeutics USD 32.96M 676K Jun/2026
Cytokinetics USD 181.43M 17.76M Jun/2026
Eisai JPY 393.64B 53.39B Jun/2026
Eli Lilly USD 47.74B 11.11B Jun/2026
Exelixis USD 361.93M 9.05M Jun/2026
Geron USD 70.33M 3.24M Jun/2026
Halozyme Therapeutics USD 344.44M 18.77M Jun/2026
Ionis Pharmaceuticals USD 315.64M 401.36M Jun/2026
Ligand Pharmaceuticals USD 46.74M 6.07M Jun/2026
Merck USD 27.73B 786M Jun/2026
Novartis USD 31.75B 374M Jun/2026
Pfizer USD 32.65B 1.7B Jun/2026
Regeneron Pharmaceuticals USD 5.53B 422.9M Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sanofi EUR 31.93B 1.92B Jun/2026